PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 140 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $13,071,000 | -64.8% | 285,091 | -54.5% | 1.41% | -1.9% |
| Q2 2018 | $37,084,000 | +29.1% | 626,950 | +48.6% | 1.43% | +25.9% |
| Q1 2018 | $28,715,000 | +228.5% | 421,966 | +322.0% | 1.14% | +578.0% |
| Q2 2017 | $8,740,000 | -48.5% | 100,000 | -78.1% | 0.17% | -61.6% |
| Q1 2017 | $16,967,000 | +23.2% | 456,097 | +1.7% | 0.44% | +64.9% |
| Q4 2016 | $13,768,000 | -21.3% | 448,471 | -23.6% | 0.26% | -24.3% |
| Q2 2016 | $17,490,000 | +319.8% | 587,126 | +1367.8% | 0.35% | +79.5% |
| Q1 2014 | $4,166,000 | – | 40,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |